Pediatrics Doctors in Poplar Bluff, MO Accepting Medicare

7 Pediatrics doctors found. Showing 1 - 7

Dr. Rangsan Suvan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2500 Lucy Lee Parkway, Poplar Bluff, MO 63901 Phone: 573-686-2585    Fax: 573-686-4415

Dr. Claudia Karin Preuschoff, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 225 Physicians Park Ste 400, Poplar Bluff, MO 63901 Phone: 573-727-5500    Fax: 573-727-5599

Gift Adanma Onyenso, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 225 Physicians Park Ste 400, Poplar Bluff, MO 63901 Phone: 573-727-5500    Fax: 573-727-5599

Dr. Debra Ann Robertson, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 225 Physicians Park Ste 400, Poplar Bluff, MO 63901 Phone: 573-727-5500    Fax: 573-727-5599

Mr. Joseph P Fernando, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2340 Katy Ln, Suite 120, Poplar Bluff, MO 63901 Phone: 573-776-7393    Fax: 573-776-7396

Dr. Shaun A Ross, MD Pediatrics - Pediatric Endocrinology Medicare: Accepting Medicare Assignments Practice Location: 225 Physicians Park Ste 400, Poplar Bluff, MO 63901 Phone: 573-727-5500    Fax: 573-727-5599

Roger Kingsley Bost, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 686 Lester St, Poplar Bluff, MO 63901 Phone: 573-686-2411    Fax: 573-686-8452

News Archive

Capillary blood microsampling could prove a breakthrough in SARS-CoV-2 serosurveillance

As COVID-19 seems to be making a comeback in many areas of the world, including Japan, a new study published on the preprint server medRxiv in October 2020 shows the relevance of microsamples of blood in serosurveillance of this disease.

Shire receives Paragraph IV Notice Letter over generic INTUNIV ANDAs from Teva Pharmaceuticals

Shire plc, announces that it has received a Paragraph IV Notice Letter from Teva Pharmaceuticals USA, Inc. advising of the filing of an Abbreviated New Drug Application for a generic version of Shire's 1 mg, 2mg, 3 mg, and 4mg guanfacine hydrochloride extended release tablets, INTUNIV(TM).

DJOFL net sales increases 10.3% to $240.1 million for first-quarter 2010

DJO Incorporated a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the first quarter of 2010, ended April 3, 2010.

New Department of Health Services Research for quality cancer care

Oncologist and cancer care outcomes researcher Sharon H. Giordano, M.D., leads the new Department of Health Services Research at The University of Texas MD Anderson Cancer Center, a multidisciplinary area of research that examines the delivery, quality and costs of health care.

Read more Medical News

› Verified 5 days ago